HKPD vs ATXG vs CNET vs BTBT vs HCWB

For growth investors, Bit Digital, Inc.

(BTBT) is the stronger pick with 264. 6% revenue growth year-over-year, versus -97. 9% for HCW Biologics Inc. (HCWB). Bit Digital, Inc. (BTBT) offers the better valuation at 9. 2x trailing P/E, making it the more compelling value choice. Analysts rate Bit Digital, Inc. (BTBT) a "Buy" — based on 2 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, Hong Kong Pharma Digital Technology Holdings Limited (HKPD) delivered a total return of -77.

3%, compared to -99. 9% for HCW Biologics Inc. (HCWB). Over 10 years, the gap is even starker: BTBT returned -60. 4% versus ATXG's -99. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), ZW Data Action Technologies Inc.

(CNET) is the lower-risk stock at 1. 18β versus Bit Digital, Inc. 's 3. 37β — meaning BTBT is approximately 186% more volatile than CNET relative to the S&P 500. On balance sheet safety, Bit Digital, Inc. (BTBT) carries a lower debt/equity ratio of 3% versus 2% for HCW Biologics Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Bit Digital, Inc.

(BTBT) is pulling ahead at 264. 6% versus -97. 9% for HCW Biologics Inc. (HCWB). On earnings-per-share growth, the picture is similar: Bit Digital, Inc. grew EPS 225. 0% year-over-year, compared to -1280. 5% for HCW Biologics Inc.. Over a 3-year CAGR, ATXG leads at -30. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Bit Digital, Inc.

(BTBT) is the more profitable company, earning 17. 3% net margin versus -146. 8% for HCW Biologics Inc. — meaning it keeps 17. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: BTBT leads at 16. 8% versus -207. 6% for HCWB. At the gross margin level — before operating expenses — BTBT leads at 61. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

In this comparison, BTBT (0.

3% yield) pays a dividend. HKPD, ATXG, CNET, HCWB do not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, ZW Data Action Technologies Inc.

(CNET) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 18)). Bit Digital, Inc. (BTBT) carries a higher beta of 3. 37 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (CNET: -97. 8%, BTBT: -60. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (HKPD (Industrials) and ATXG (Industrials) and CNET (Communication Services) and BTBT (Financial Services) and HCWB (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: HKPD is a small-cap high-growth stock; ATXG is a small-cap quality compounder stock; CNET is a small-cap quality compounder stock; BTBT is a small-cap high-growth stock; HCWB is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.